{
    "nctId": "NCT01615068",
    "briefTitle": "An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)",
    "officialTitle": "An Observational Cohort Study of Treatment Patterns and Outcomes in Patients With HER2 Positive (HER2+) Metastatic Breast Cancer (SystHERs Registry (Systemic Therapies for HER2+ Metastatic Breast Cancer Study)).",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1007,
    "primaryOutcomeMeasure": "Distribution of patients receiving unique treatment regimen/sequence of treatment regimens",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients, \\>/=18 years of age\n* Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment\n* Availability of cancer-specific historical data points in the patient's medical records\n\nExclusion Criteria:\n\n* Any inability to provide informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}